{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:09:19Z","timestamp":1788804559213,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007471","name":"Northern Borders University","doi-asserted-by":"publisher","award":["NBU-FFR-2026-2510-06"],"award-info":[{"award-number":["NBU-FFR-2026-2510-06"]}],"id":[{"id":"10.13039\/501100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01213-0","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:43:07Z","timestamp":1788540187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Icariin-loaded liposomal nanoparticles alleviate streptozotocin-induced diabetic hepatopathy associated with modulation of ferroptosis-related and inflammatory signaling"],"prefix":"10.1186","volume":"27","author":[{"given":"Badriah A.","family":"Hifni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza A.","family":"Alyamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat B.","family":"Al-Ghafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda A.","family":"Al Doghaither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekramy M.","family":"Elmorsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal S.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad E.","family":"Elshopakey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"1213_CR1","doi-asserted-by":"publisher","first-page":"115734","DOI":"10.1016\/j.biopha.2023.115734","volume":"168","author":"SA Antar","year":"2023","unstructured":"Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, Roh EJ, Elkamhawy A, Al-Karmalawy AA. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother. 2023;168:115734.","journal-title":"Biomed Pharmacother"},{"key":"1213_CR2","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Mart\u00edn C. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21:6275.","journal-title":"Int J Mol Sci"},{"key":"1213_CR3","doi-asserted-by":"publisher","first-page":"e2004","DOI":"10.1002\/hsr2.2004","volume":"7","author":"MJ Hossain","year":"2024","unstructured":"Hossain MJ, Al-Mamun M, Islam MR. Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Sci Rep. 2024;7:e2004.","journal-title":"Health Sci Rep"},{"key":"1213_CR4","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3390\/nu15102323","volume":"15","author":"N Bhat","year":"2023","unstructured":"Bhat N, Mani A. Dysregulation of lipid and glucose metabolism in nonalcoholic fatty liver disease. Nutrients. 2023;15:2323.","journal-title":"Nutrients"},{"key":"1213_CR5","first-page":"752","volume":"14","author":"H Fuentes-Barr\u00eda","year":"2026","unstructured":"Fuentes-Barr\u00eda H, Aguilera-Egu\u00eda R, Flores-Fern\u00e1ndez C, Angarita-Davila L, Alarc\u00f3n-Rivera M. Type 2 Diabetes Mellitus as a Multisystem Disease: From Insulin Resistance to Organ Crosstalk\u2014A. Narrative Rev Biomedicines. 2026;14:752.","journal-title":"Narrative Rev Biomedicines"},{"key":"1213_CR6","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.3390\/ijms24119352","volume":"24","author":"P Gonz\u00e1lez","year":"2023","unstructured":"Gonz\u00e1lez P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24:9352.","journal-title":"Int J Mol Sci"},{"key":"1213_CR7","doi-asserted-by":"publisher","first-page":"e70268","DOI":"10.1002\/mco2.70268","volume":"6","author":"S Liu","year":"2025","unstructured":"Liu S, Liu J, Wang Y, Deng F, Deng Z. Oxidative stress: signaling pathways, biological functions, and disease. MedComm. 2025;6:e70268.","journal-title":"MedComm"},{"key":"1213_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41420-025-02780-7","volume":"11","author":"X Li","year":"2025","unstructured":"Li X, Fang M, Liu X, Jiang J, Wang S, Mao X, Zou Z, Jin W. Ferroptosis in diabetes mellitus and its complications: overview of clinical and preclinical research. Cell Death Discovery. 2025;11:504.","journal-title":"Cell Death Discovery"},{"key":"1213_CR9","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"F-J Li","year":"2022","unstructured":"Li F-J, Long H-Z, Zhou Z-W, Luo H-Y, Xu S-G, Gao L-C. System Xc\u2013\/GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol. 2022;13:910292.","journal-title":"Front Pharmacol"},{"key":"1213_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","volume":"10","author":"X Jin","year":"2024","unstructured":"Jin X, Tang J, Qiu X, Nie X, Ou S, Wu G, Zhang R, Zhu J. Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. Cell Death Discovery. 2024;10:45.","journal-title":"Cell Death Discovery"},{"key":"1213_CR11","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.biopha.2018.11.108","volume":"109","author":"Y-d Zhou","year":"2019","unstructured":"Zhou Y-d, Hou J-g, Yang G, Jiang S, Chen C, Wang Z, Liu Y-y, Ren S, Li W. Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K\/Akt pathway. Biomed Pharmacother. 2019;109:2309\u201317.","journal-title":"Biomed Pharmacother"},{"key":"1213_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41419-024-07224-1","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Jiang Z, Li X. New insights into crosstalk between Nrf2 pathway and ferroptosis in lung disease. Cell Death Dis. 2024;15:841.","journal-title":"Cell Death Dis"},{"key":"1213_CR13","doi-asserted-by":"publisher","first-page":"1294317","DOI":"10.3389\/fimmu.2023.1294317","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Li L, Zhang Z, Chen P, Shu H, Yang C, Chu Y, Liu J. Ferroptosis: an important player in the inflammatory response in diabetic nephropathy. Front Immunol. 2023;14:1294317.","journal-title":"Front Immunol"},{"key":"1213_CR14","doi-asserted-by":"publisher","first-page":"118020","DOI":"10.1016\/j.biopha.2025.118020","volume":"186","author":"R Ebrahimi","year":"2025","unstructured":"Ebrahimi R, Mohammadpour A, Medoro A, Davinelli S, Saso L, Miroliaei M. Exploring the links between polyphenols, Nrf2, and diabetes: A review. Biomed Pharmacother. 2025;186:118020.","journal-title":"Biomed Pharmacother"},{"key":"1213_CR15","doi-asserted-by":"publisher","first-page":"4538420","DOI":"10.1155\/omcl\/4538420","volume":"2026","author":"VB Costa","year":"2026","unstructured":"Costa VB, de Matos IA, Nogueira IR, de Godoi MA, Leite FR, Guimar\u00e3es-Stabili MR. Nrf2 Activation in Inflammatory Diseases: A Review of Natural and Synthetic Modulators. Oxidative Med Cell Longev. 2026;2026:4538420.","journal-title":"Oxidative Med Cell Longev"},{"key":"1213_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05573-6","author":"A Al Mansoori","year":"2026","unstructured":"Al Mansoori A, Baig B, Harati R, Alhamidi RS, Hamza AA, Al-Salam S, Le A, Zhang C, Khare P, Hamoudi R, Amin A. Safranal improves the anticancer efficacy of sorafenib via transcriptomic reprogramming and metabolomic changes in a rat model of diethylnitrosamine-induced cirrhosis-hepatocellular carcinoma. Naunyn Schmiedebergs Arch Pharmacol. 2026. https:\/\/doi.org\/10.1007\/s00210-026-05573-6.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1213_CR17","doi-asserted-by":"publisher","first-page":"9566","DOI":"10.1038\/s41598-025-93120-3","volume":"15","author":"MAM Ali","year":"2025","unstructured":"Ali MAM, Matouk AI, Hamza AA, Amin A, Heeba GH. Gallic and glycyrrhetinic acids prevent azithromycin-induced liver damage in rats by mitigating oxidative stress and inflammation. Sci Rep. 2025;15:9566. https:\/\/doi.org\/10.1038\/s41598-025-93120-3.","journal-title":"Sci Rep"},{"key":"1213_CR18","doi-asserted-by":"publisher","first-page":"1353029","DOI":"10.3389\/fphar.2024.1353029","volume":"15","author":"SR Botros","year":"2024","unstructured":"Botros SR, Matouk AI, Amin A, Heeba GH. Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1\/Nrf2\/NF-\u03baB\/TNF-\u03b1 signaling pathways. Front Pharmacol. 2024;15:1353029. https:\/\/doi.org\/10.3389\/fphar.2024.1353029.","journal-title":"Front Pharmacol"},{"key":"1213_CR19","doi-asserted-by":"publisher","first-page":"850066","DOI":"10.3389\/fphar.2022.850066","volume":"13","author":"R Abdel-Latif","year":"2022","unstructured":"Abdel-Latif R, Heeba GH, Hassanin SO, Waz S, Amin A. TLRs-JNK\/ NF-\u03baB Pathway Underlies the Protective Effect of the Sulfide Salt Against Liver Toxicity. Front Pharmacol. 2022;13:850066. https:\/\/doi.org\/10.3389\/fphar.2022.850066.","journal-title":"Front Pharmacol"},{"key":"1213_CR20","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1039\/d0na00958j","volume":"3","author":"E Benassi","year":"2021","unstructured":"Benassi E, Fan H, Sun Q, Dukenbayev K, Wang Q, Shaimoldina A, Tassanbiyeva A, Nurtay L, Nurkesh A, Kutzhanova A, Mu C, Dautov A, Razbekova M, Kabylda A, Yang Q, Li Z, Amin A, Li X, Xie Y. Generation of particle assemblies mimicking enzymatic activity by processing of herbal food: the case of rhizoma polygonati and other natural ingredients in traditional Chinese medicine. Nanoscale Adv. 2021;3:2222\u201335. https:\/\/doi.org\/10.1039\/d0na00958j.","journal-title":"Nanoscale Adv"},{"key":"1213_CR21","doi-asserted-by":"publisher","first-page":"1606912","DOI":"10.3389\/fphar.2025.1606912","volume":"16","author":"J Luo","year":"2025","unstructured":"Luo J, Wu L, Xu Y, Zhang J, Zhao X, Wang X. The therapeutic potential of icariin in the intervention of bone and joint diseases through multiple pathways: a narrative review. Front Pharmacol. 2025;16:1606912.","journal-title":"Front Pharmacol"},{"key":"1213_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13098-025-01760-2","volume":"17","author":"X Man","year":"2025","unstructured":"Man X, Ren P, Jin J, He Q. Preclinical evidence of the effect of icariin on diabetic nephropathy: a systematic review and meta-analysis. Diabetol Metab Syndr. 2025;17:222.","journal-title":"Diabetol Metab Syndr"},{"key":"1213_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/molecules28020517","volume":"28","author":"Y Hai","year":"2023","unstructured":"Hai Y, Zuo L, Wang M, Zhang R, Wang M, Ren L, Yang C, Wang J. Icariin alleviates nonalcoholic fatty liver disease in polycystic ovary syndrome by improving liver fatty acid oxidation and inhibiting lipid accumulation. Molecules. 2023;28:517.","journal-title":"Molecules"},{"key":"1213_CR24","doi-asserted-by":"crossref","unstructured":"Guo X, Qin Y, Feng Z, Li H, Yang J, Su K, Mao R, Li J. (2024) Investigating the anti-inflammatory effects of icariin: a combined meta-analysis and machine learning study. Heliyon 10.","DOI":"10.1016\/j.heliyon.2024.e35307"},{"key":"1213_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jphs.2024.02.013","volume":"154","author":"K Wang","year":"2024","unstructured":"Wang K, Hou M, Qiao C, Duan Y, Tao R, Wang X, Xiao K, Liu S, Zhao H, Wang J. Icariin alleviates diabetic renal interstitial fibrosis aggravation by inhibiting miR-320a-3p targeting BMP6. J Pharmacol Sci. 2024;154:316\u201325.","journal-title":"J Pharmacol Sci"},{"key":"1213_CR26","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1002\/ptr.7939","volume":"37","author":"KY Wong","year":"2023","unstructured":"Wong KY, Kong TH, Poon CCW, Yu W, Zhou L, Wong MS. Icariin, a phytoestrogen, exerts rapid estrogenic actions through crosstalk of estrogen receptors in osteoblasts. Phytother Res. 2023;37:4706\u201321.","journal-title":"Phytother Res"},{"key":"1213_CR27","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.3390\/ijms23147519","volume":"23","author":"R Szab\u00f3","year":"2022","unstructured":"Szab\u00f3 R, R\u00e1cz CP, Dulf FV. Bioavailability improvement strategies for icariin and its derivates: a review. Int J Mol Sci. 2022;23:7519.","journal-title":"Int J Mol Sci"},{"key":"1213_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","volume":"14","author":"SZ Alshawwa","year":"2022","unstructured":"Alshawwa SZ, Kassem AA, Farid RM, Mostafa SK, Labib GS. Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics. 2022;14:883.","journal-title":"Pharmaceutics"},{"key":"1213_CR29","doi-asserted-by":"publisher","unstructured":"Elmehrath S, Nguyen HL, Karam SM, Amin A, Greish YE. BioMOF-based anti-cancer drug delivery systems. Nanomaterials (Basel). 2023;13. https:\/\/doi.org\/10.3390\/nano13050953.","DOI":"10.3390\/nano13050953"},{"key":"1213_CR30","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.1039\/d1na00475a","volume":"3","author":"G Nazarbek","year":"2021","unstructured":"Nazarbek G, Kutzhanova A, Nurtay L, Mu C, Kazybay B, Li X, Ma C, Amin A, Xie Y. Nano-evolution and protein-based enzymatic evolution predicts novel types of natural product nanozymes of traditional Chinese medicine: cases of herbzymes of Taishan-Huangjing (Rhizoma polygonati) and Goji (Lycium chinense). Nanoscale Adv. 2021;3:6728\u201338. https:\/\/doi.org\/10.1039\/d1na00475a.","journal-title":"Nanoscale Adv"},{"key":"1213_CR31","doi-asserted-by":"crossref","unstructured":"Izadiyan Z, Misran M, Kalantari K, Webster TJ, Kia P, Basrowi NA, Rasouli E, Shameli K. (2025) Advancements in liposomal nanomedicines: Innovative formulations, therapeutic applications, and future directions in precision medicine. Int J Nanomed:1213\u201362.","DOI":"10.2147\/IJN.S488961"},{"key":"1213_CR32","first-page":"e1955","volume":"16","author":"Z Xun","year":"2024","unstructured":"Xun Z, Li T, Xue X. The application strategy of liposomes in organ targeting therapy. Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol. 2024;16:e1955.","journal-title":"Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol"},{"key":"1213_CR33","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/jphp.13314","volume":"72","author":"J Wang","year":"2020","unstructured":"Wang J, Zhu G, Wang X, Cai J, Xie L, Zheng W, Feng Y, Guo Q, Chen H, Cai L. An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury. J Pharm Pharmacol. 2020;72:1152\u201364.","journal-title":"J Pharm Pharmacol"},{"key":"1213_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4236\/jdm.2015.54033","volume":"5","author":"MS Demoz","year":"2015","unstructured":"Demoz MS, Gachoki KP, Mungai KJ, Negusse BG. Evaluation of the anti-diabetic potential of the methanol extracts of aloe camperi, meriandra dianthera and a polyherb. J Diabetes Mellitus. 2015;5:267\u201376.","journal-title":"J Diabetes Mellitus"},{"key":"1213_CR35","doi-asserted-by":"crossref","unstructured":"MH EN, Fadlalla I, AM, IH. Histopathological alteration in STZ-nicotinamide diabetic rats, a complication of diabetes or a toxicity of STZ? Int J Diabetes Clin Res 2018;5.","DOI":"10.23937\/2377-3634\/1410091"},{"key":"1213_CR36","doi-asserted-by":"publisher","first-page":"720387","DOI":"10.3389\/fphar.2021.720387","volume":"12","author":"Z Jia","year":"2021","unstructured":"Jia Z, Wang K, Zhang Y, Duan Y, Xiao K, Liu S, Ding X. Icariin ameliorates diabetic renal tubulointerstitial fibrosis by restoring autophagy via regulation of the miR-192-5p\/GLP-1R pathway. Front Pharmacol. 2021;12:720387.","journal-title":"Front Pharmacol"},{"key":"1213_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"1213_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4093\/dmj.2023.0350","volume":"48","author":"I Jung","year":"2024","unstructured":"Jung I, Koo D-J, Lee W-Y. Insulin resistance, non-alcoholic fatty liver disease and type 2 diabetes mellitus: clinical and experimental perspective. Diabetes metabolism J. 2024;48:327\u201339.","journal-title":"Diabetes metabolism J"},{"key":"1213_CR39","first-page":"102069","volume":"43","author":"A Yesupatham","year":"2025","unstructured":"Yesupatham A, Saraswathy R. Role of oxidative stress in prediabetes development. Biochem Biophys Rep. 2025;43:102069.","journal-title":"Biochem Biophys Rep"},{"key":"1213_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejphar.2015.03.059","volume":"758","author":"Y Han","year":"2015","unstructured":"Han Y, Jung HW, Park Y-K. Effects of Icariin on insulin resistance via the activation of AMPK pathway in C2C12 mouse muscle cells. Eur J Pharmacol. 2015;758:60\u20133.","journal-title":"Eur J Pharmacol"},{"key":"1213_CR41","doi-asserted-by":"publisher","first-page":"49119","DOI":"10.1039\/D5RA07152F","volume":"15","author":"M Umar","year":"2025","unstructured":"Umar M, Sherazi TA, Talha M, Ramadan MF, Ahmed AE, Taha R, Naqvi SAR. Nanoliposome-based drug delivery systems for the treatment of diabetes mellitus: a review. RSC Adv. 2025;15:49119\u201343.","journal-title":"RSC Adv"},{"key":"1213_CR42","doi-asserted-by":"publisher","first-page":"6559","DOI":"10.3390\/ijms21186559","volume":"21","author":"KN Belosludtsev","year":"2020","unstructured":"Belosludtsev KN, Belosludtseva NV, Dubinin MV. Diabetes mellitus, mitochondrial dysfunction and Ca2+-dependent permeability transition pore. Int J Mol Sci. 2020;21:6559.","journal-title":"Int J Mol Sci"},{"key":"1213_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40842-025-00247-3","volume":"11","author":"A Hussain","year":"2025","unstructured":"Hussain A. Chronic hyperglycemia and cardiovascular dysfunction: an in-depth exploration of metabolic and cellular pathways in type 2 diabetes mellitus. Cardiovasc Diabetology\u2013Endocrinology Rep. 2025;11:39.","journal-title":"Cardiovasc Diabetology\u2013Endocrinology Rep"},{"key":"1213_CR44","first-page":"35","volume":"5","author":"EY Ali","year":"2024","unstructured":"Ali EY, Abu-Elsaoud A, Moghzi MM, Marie OM. Ethanolic Extract of Orange Leaves Ameliorates Dyslipidemia in Streptozotocin-induced Diabetic Rats. Adv Environ Life Sci. 2024;5:35\u201341.","journal-title":"Adv Environ Life Sci"},{"key":"1213_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.redox.2016.11.003","volume":"11","author":"J Wu","year":"2017","unstructured":"Wu J, Jin Z, Yan L-J. Redox imbalance and mitochondrial abnormalities in the diabetic lung. Redox Biol. 2017;11:51\u20139.","journal-title":"Redox Biol"},{"key":"1213_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.13005\/bbra\/3484","volume":"23","author":"BM Reddy","year":"2026","unstructured":"Reddy BM, Zameer N, Shruthi P, Archita N. Redox Imbalance and Oxidative Stress in Diabetes Mellitus: Mechanistic Insights into Complications and Antioxidant-Based Therapeutic Perspectives. Biosci Biotechnol Res Asia. 2026;23:117\u201328.","journal-title":"Biosci Biotechnol Res Asia"},{"key":"1213_CR47","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3390\/ijms18122772","volume":"18","author":"S Vomund","year":"2017","unstructured":"Vomund S, Sch\u00e4fer A, Parnham MJ, Br\u00fcne B, Von Knethen A. Nrf2, the master regulator of anti-oxidative responses. Int J Mol Sci. 2017;18:2772.","journal-title":"Int J Mol Sci"},{"key":"1213_CR48","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3389\/fphar.2018.00819","volume":"9","author":"I Lazaro","year":"2018","unstructured":"Lazaro I, Lopez-Sanz L, Bernal S, Oguiza A, Recio C, Melgar A, Jimenez-Castilla L, Egido J, Madrigal-Matute J, Gomez-Guerrero C. Nrf2 activation provides atheroprotection in diabetic mice through concerted upregulation of antioxidant, anti-inflammatory, and autophagy mechanisms. Front Pharmacol. 2018;9:819.","journal-title":"Front Pharmacol"},{"key":"1213_CR49","doi-asserted-by":"publisher","first-page":"690545","DOI":"10.1155\/2013\/690545","volume":"2013","author":"UC Yadav","year":"2013","unstructured":"Yadav UC, Ramana KV. Regulation of NF-\u03baB\u2010Induced Inflammatory Signaling by Lipid Peroxidation\u2010Derived Aldehydes. Oxidative Med Cell Longev. 2013;2013:690545.","journal-title":"Oxidative Med Cell Longev"},{"key":"1213_CR50","doi-asserted-by":"publisher","first-page":"115502","DOI":"10.1016\/j.biopha.2023.115502","volume":"167","author":"L Mobasheri","year":"2023","unstructured":"Mobasheri L, Ahadi M, Namdar AB, Alavi MS, Bemidinezhad A, Farahi SMM, Esmaeilizadeh M, Nikpasand N, Einafshar E, Ghorbani A. Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals. Biomed Pharmacother. 2023;167:115502.","journal-title":"Biomed Pharmacother"},{"key":"1213_CR51","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/antiox13070797","volume":"13","author":"K Mohammadian","year":"2024","unstructured":"Mohammadian K, Fakhar F, Keramat S, Stanek A. The role of antioxidants in the treatment of metabolic dysfunction-associated fatty liver disease: a systematic review. Antioxidants. 2024;13:797.","journal-title":"Antioxidants"},{"key":"1213_CR52","doi-asserted-by":"publisher","first-page":"10240","DOI":"10.3390\/ijms262010240","volume":"26","author":"N Sendtner","year":"2025","unstructured":"Sendtner N, Seitz R, Brandl N, M\u00fcller M, G\u00fclow K. Reactive oxygen species across death pathways: Gatekeepers of apoptosis, ferroptosis, pyroptosis, paraptosis, and beyond. Int J Mol Sci. 2025;26:10240.","journal-title":"Int J Mol Sci"},{"key":"1213_CR53","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biom12040542","volume":"12","author":"M Khalid","year":"2022","unstructured":"Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12:542.","journal-title":"Biomolecules"},{"key":"1213_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lfs.2010.06.007","volume":"87","author":"A Dey","year":"2010","unstructured":"Dey A, Swaminathan K. Hyperglycemia-induced mitochondrial alterations in liver. Life Sci. 2010;87:197\u2013214.","journal-title":"Life Sci"},{"key":"1213_CR55","doi-asserted-by":"publisher","first-page":"2198323","DOI":"10.1155\/2017\/2198323","volume":"2017","author":"X Deng","year":"2017","unstructured":"Deng X, Wu W, Liang H, Huang D, Jing D, Zheng D, Shao Z. Icariin Prevents IL-1\u03b2\u2010Induced Apoptosis in Human Nucleus Pulposus via the PI3K\/AKT Pathway. Evidence\u2010Based Complement Altern Med. 2017;2017:2198323.","journal-title":"Evidence\u2010Based Complement Altern Med"},{"key":"1213_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40779-025-00665-5","volume":"12","author":"H-T Zhou","year":"2025","unstructured":"Zhou H-T, Huang J, Liu Y-K, Wang J-H, Wang J. The emerging role of ferroptosis in the pathological development and progression of sepsis. Military Med Res. 2025;12:81.","journal-title":"Military Med Res"},{"key":"1213_CR57","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41420-025-02744-x","volume":"11","author":"S Singh","year":"2025","unstructured":"Singh S, Mohapatra I, Barik D, Zheng H, Kim S, Sharma M, Chen CC, Singh G. Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance. Cell Death Discovery. 2025;11:448.","journal-title":"Cell Death Discovery"},{"key":"1213_CR58","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/antiox12091653","volume":"12","author":"A Allameh","year":"2023","unstructured":"Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K. Oxidative stress in liver pathophysiology and disease. Antioxidants. 2023;12:1653.","journal-title":"Antioxidants"},{"key":"1213_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target therapy. 2024;9:271.","journal-title":"Signal Transduct Target therapy"},{"key":"1213_CR60","doi-asserted-by":"publisher","first-page":"103551","DOI":"10.1016\/j.redox.2025.103551","volume":"81","author":"Y Dong","year":"2025","unstructured":"Dong Y, Zheng M, Ding W, Guan H, Xiao J, Li F. Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside. Redox Biol. 2025;81:103551.","journal-title":"Redox Biol"},{"key":"1213_CR61","doi-asserted-by":"publisher","first-page":"100020","DOI":"10.1016\/j.clnves.2025.100020","volume":"1","author":"S Zhu","year":"2025","unstructured":"Zhu S, Hou J, Li Y, Deng W, Wang Z, Qiao M, Dai Z, Huang J, Jiang L, Huang J. Activation of the NRF2 signaling pathway mitigates arthrofibrosis by suppressing myofibroblast ferroptosis through oxidative stress regulation. Cell Invest. 2025;1:100020.","journal-title":"Cell Invest"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01213-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:03:01Z","timestamp":1788804181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01213-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01213-0","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for all procedures was obtained from the Mansoura University Animal Care and Use Committee (MU- ACUC-M.V.R.26.6.295). The study adhered to Directive 2010\/63\/EU and was conducted in accordance with the ARRIVE guidelines 2.0, ensuring the protection of animals used for scientific purposes.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"123"}}